Ownership

David Watson - General Counsel at Apellis Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type: Individual
Role: General Counsel
Stock Symbol: APLS on Nasdaq
Industry: Pharmaceutical Preparations
All Insider Reports: All Insider Reports

David Watson - trading volume in the past year for Apellis Pharmaceuticals, Inc.

	Shares	%	Avg Price	Total $
Buys
Sells	-21.8K	100%	$29.47	-$641K
Net	-21.8K	-100%		-$641K

Holdings reported by David Watson for Apellis Pharmaceuticals, Inc.

Security	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common Stock	139K	$3.48M	$25.10	Mar 5, 2025	Direct
Common Stock	70.1K	$1.76M	$25.10	Mar 4, 2025	Indirect Owner (The David O. Watson Irrevocable Trust of 2023)
Common Stock	10K	$251K	$25.10	Mar 4, 2025	Indirect Owner (Custodial Account for Son)
Common Stock	0	$0	$25.10	Mar 4, 2025	Indirect Owner (The Watson Education Trust)
Stock Option (Right to Buy)	0	$0	$66.30	Mar 6, 2024	Direct	Common Stock

Transactions reported by David Watson for Apellis Pharmaceuticals, Inc.

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.